Dr James R Revenaugh, MD | |
5169 Cottonwood St, Bldg. B, Suite 520, Murray, UT 84107-6767 | |
(801) 507-3500 | |
(801) 507-3550 |
Full Name | Dr James R Revenaugh |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 5169 Cottonwood St, Murray, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316915952 | NPI | - | NPPES |
002084158 | Medicaid | NV | |
805051500 | Medicaid | ID | |
D1851 | Medicaid | UT | |
060052374 | Other | RR MEDICARE | |
113027700 | Medicaid | WY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 333439 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr James R Revenaugh, MD 5169 Cottonwood St, Bldg. B, Suite 520, Murray, UT 84107-6767 Ph: (801) 507-3500 | Dr James R Revenaugh, MD 5169 Cottonwood St, Bldg. B, Suite 520, Murray, UT 84107-6767 Ph: (801) 507-3500 |
News Archive
Many patients with cardiovascular disease are not given adequate drug therapy.
Fifty-five years ago, America's death toll from automobile crashes was sky-high. Nearly 50,000 people died every year from motor vehicle crashes, at a time when the nation's population was much smaller than today.
NPS Pharmaceuticals, Inc. today announced that it intends to offer, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering. In connection with this offering, the Company expects to grant to the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock to cover overallotments, if any.
Janssen Research & Development, LLC has initiated the rolling submission of its Biologic License Application (BLA) for daratumumab to the U.S. Food and Drug Administration (FDA) for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD), or who are double refractory to a PI and an IMiD.
› Verified 9 days ago
Bogdan Ciprian Anea, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: Intermountain Kidney Services Clinic, 5169 South Cottonwood Street, Suite 320, Murray, UT 84107 Phone: 801-507-2531 Fax: 801-507-2597 | |
E Dennis Genebach, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 5801 Fashion Blvd, Murray, UT 84107 Phone: 801-314-4544 | |
Dr. Samuel Morris Brown, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-507-6415 | |
Dr. Jamie Lynn Rebman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5121 Cottonwood Rd, Suite 610, Murray, UT 84107 Phone: 801-507-3630 Fax: 801-507-3630 | |
Dr. Kia Afshar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5169 S Cottonwood St Ste 520, Murray, UT 84107 Phone: 801-507-4701 | |
Rachel Elizabeth Hu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 610, Murray, UT 84107 Phone: 801-507-3900 Fax: 801-507-3640 | |
Caroline Nebhan, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 610, Murray, UT 84107 Phone: 801-507-3630 |